Route of administration is how a compound enters your body and changes timing, consistency, and safety assumptions.
Why it matters
An incorrect route assumption can produce false dose confidence and unpredictable symptom signals.
Practical route comparisons
- oral vs sublingual: onset and gastric impact differences
- topical/transdermal: slower onset, local tolerance, adherence complexity
- timed-release and special matrix formats: delayed peaks and extended action
Common user errors
- logging route as oral when timing matches sublingual use
- ignoring food/pH effects on oral absorption
- splitting products without updating serving-to-route context
Practical action step
Record both route and timing on every entry when route impacts are likely, especially for compounds with GI or stimulant sensitivity.
Uncertainty and limits
- Evidence is limited on route-specific behavior for every formulation and compound.
- Evidence is limited on direct route comparability across different manufacturers.
Cross-site references
How this appears in Unfair
Route data informs timing windows, dosage interpretation, and warnings when exposure assumptions are not matching reported outcomes.
Clinical safety note
If route-related discomfort or unexpected effects appear, pause and reassess with clinician input before resuming.